Comparison of fixed dose (6 MG) pegfilgrastim and daily filgrastim to accelerate hemopoietic recovery after autologous stem cell transplantation (ASCT)

被引:0
|
作者
Marcacci, G
Petti, MC
Ferrara, F
Scarpato, N
Storti, S
D'Arena, G
Palombi, F
Palmieri, S
Andretta, C
Pinto, A
机构
[1] IRCCS, Fdz Pascale, Hematol Oncol & Bone Marrow Transplantat Unit, NCI, Naples, Italy
[2] Regina Elena IRCCS, Hematol Unit, NCI, Rome, Italy
[3] AORN Cardarelli, Hematol & BNT Unit, Naples, Italy
[4] AOU Federico 2, Hamephereis Unit, Naples, Italy
[5] Catholic Univ, Hematol Oncol Unit, Campobasso, Italy
关键词
D O I
10.1016/j.bbmt.2005.11.288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
265
引用
收藏
页码:94 / 94
页数:1
相关论文
共 50 条
  • [31] PEG-filgrastim after autologous stem cell transplantation
    De Rosa, G.
    Montante, B.
    Becchimanzi, C.
    De Rosa, A.
    Cacciapuoti, C.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 230 - 230
  • [32] Successful engraftment of autologous CD34+stem cells after high-dose therapy and fixed dose (6 mg) pegfilgrastim.
    Marcacci, G
    Petti, MC
    Ferrara, F
    Storti, S
    D'Arena, G
    Palombi, F
    Palmieri, S
    Giordano, G
    Pinto, A
    BLOOD, 2005, 106 (11) : 768A - 768A
  • [33] Filgrastim XM02 (Tevagrastim) after autologous stem cell transplantation (ASCT): favourable cost-efficacy effect in comparison with lenograstim
    Gardellini, A.
    Gigli, F.
    Babic, A.
    Andreola, G.
    Radice, D.
    Martinelli, G.
    Laszlo, D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S458 - S458
  • [34] A comparative study of pegfilgrastim versus daiily filgrastim after high dose melphalan and autologous peripheral blood stem cell transplantation in multiple myeloma patients
    Martino, M.
    Pratico, G.
    Console, G.
    Irrera, G.
    Massara, E.
    Callea, V
    Stelitano, C.
    Molica, S.
    Morabito, F.
    Piro, E.
    Quartarone, E.
    Musolino, C.
    Brugiatelli, M.
    Iacopino, P.
    ANNALS OF ONCOLOGY, 2006, 17 : XI56 - XI56
  • [35] COMPARISON OF PEGFILGRASTIM VS FILGRASTIM IN HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELLS TRANSPLANT
    Martinez, M.
    Rivera Fong, L.
    Valero Saldana, L. M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S520 - S521
  • [36] Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma
    Rifkin, Robert
    Spitzer, Gary
    Orloff, Gregory
    Mandanas, Romeo
    McGaughey, Dean
    Zhan, Feng
    Boehm, Kristi A.
    Asmar, Lina
    Beveridge, Roy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (03): : 186 - 191
  • [37] Successfull engraftment of autologous CD34+Stem Cell Transplantation after high dose therapy and single 6 mg administration of Peg-Filgrastim
    Marcacci, G.
    D'Arena, G.
    Vigliotti, M. L.
    Della Cioppa, P.
    Svanera, G.
    Nasuti, A.
    Capobianco, G.
    Villani, O.
    Corazzelli, G.
    Frigeri, F.
    Russo, F.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 453 - 453
  • [38] Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy
    Kim, IH
    Park, SK
    Suh, OK
    Oh, JM
    CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) : 753 - 759
  • [39] Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Srour, Samer A.
    Milton, Denai
    Bashir, Qaiser
    Mehta, Rohtesh S.
    Delgado, Ruby
    Rondon, Gabriela
    Nieto, Yago
    Hosing, Chitra M.
    Popat, Uday R.
    Ciurea, Stefan O.
    Patel, Krina
    Lee, Hans C.
    Manasanch, Elisabet
    Thomas, Sheeba
    Weber, Donna
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [40] Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation
    Deliliers, GL
    Annaloro, C
    Pozzoli, E
    Oriani, A
    Della Volpe, A
    Soligo, D
    Deliliers, DL
    Tagliaferri, E
    Bertolli, V
    Romitti, L
    LEUKEMIA RESEARCH, 1999, 23 (03) : 291 - 297